Impact of the recall period on measuring health utilities for acute events

Health Economics

Volumn 17, Issue 12, 2008, Pages 1413-1419

  Bansback, Nick ^a   Sun, Huiying ^a   Guh, Daphne P ^a   Li, Xin ^a,b   Nosyk, Bohdan ^a   Griffin, Susan ^c   Barnett, Paul G ^d   Anis, Aslam H ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF YORK   (United Kingdom)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Health utilities; Recall

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HEALTH CARE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RECALL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; REGRESSION ANALYSIS;

EID: 57749092448     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1351     Document Type: Article

References (21)

1. Brazier J, Roberts J, Deverill M. 2002. The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics 21: 271-292.
2. Brooks R. 1996. EuroQol: the current state of play. Health Policy 37: 53-72.
3. Brown ST, Singer J, Anis A, Kyriakides TC, Cameron W, Holodniy M et al. 2004. Non-AIDS serious adverse events are as important as AIDS events in patients with advanced multi-drug resistant HIV disease. International Conference on AIDS, vol. 15. MoPeD3841.
4. Dolan P, Gudex C, Kind P, Williams A. 1995. A social tariff for EuroQol: results from a UK general population survey. Centre for Health Economics, University of York.
5. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S et al. 2002. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical Care 40: 113-128.
6. Horsman J, Furlong W, Feeny D, Torrance G. 2003. The Health Utilities Index (HUI(R)): concepts, measurement properties and applications. Health and Quality of Life Outcomes 16(1): 54.
7. Howard GS, Ralph KM, Gulanick NA, Maxwell SE, Nance SW, Gerber SK. 1979. Internal invalidity in pretest-post test self-report evaluations and a reevaluation of retrospective pretests. Applied Psychological Measurement 3: 1-23.
8. Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ. 2005. Valuations of EQ-5D health states: are the United States and United Kingdom different? Medical Care 43: 221-228.
9. Keller SD, Bayliss MS, Ware Jr JE, Hsu MA, Damiano AM, Goss TF. 1997. Comparison of responses to SF-36 Health Survey questions with one-week and four-week recall periods. Health Services Research 32: 367-384.
10. Kopec JA, Willison KD. 2003. A comparative review of four preference-weighted measures of health-related quality of life. Journal of Clinical Epidemiology 56: 317-325.
11. Kyriakides TC, Babiker A, Singer J, Cameron W, Schechter MT, Holodniy M, Brown ST, Youle M, Gazzard B, OPTIMA Study Team. 2003. An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA trial. Controlled Clinical Trials 24: 481-500.
12. Litwin MS, McGuigan KA. 1999. Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer. Journal of Clinical Oncology 17: 2882-2888.
13. Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. 2005. Self-reported health status of the general adult US population as assessed by the EQ-5D and Health Utilities Index. Medical Care 43: 1078-1086.
14. Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH. 2005. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science & Medicine 60: 1571-1582.
15. Meyer BD. 1995. Natural and quasi-experiment in economics. Journal of Business and Economic Statistics 13: 151-161.
16. Pickard AS, Johnson JA, Feeny DH. 2005. Responsiveness of generic health-related quality of life measures in stroke. Quality of Life Research 14: 207-219.
17. Schwartz CE, Sprangers MAG. 1999. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Social Science & Medicine 48: 1531-1548.
18. Shaw JW, Johnson JA, Coons SJ. 2005. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Medical Care 43(3): 203-220.
19. Torrance GW, Boyle MH, Horwood SP. 1982. Application of multi-attribute utility theory to measure social preferences for health states. Operations Research 30: 1043-1069.
20. Torrance GW, Furlong W, Feeny D, Boyle M. 1995. Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics 7: 503-520.
21. Tsuchiya A, Brazier J, Roberts J. 2006. Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. Journal of Health Economics 25: 334-346.